Rachel Kurtzman

ORCID: 0000-0003-2511-2001
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer survivorship and care
  • Smoking Behavior and Cessation
  • Media Influence and Health
  • Head and Neck Cancer Studies
  • Delphi Technique in Research
  • Vaccine Coverage and Hesitancy
  • Cervical Cancer and HPV Research
  • Behavioral Health and Interventions
  • Palliative Care and End-of-Life Issues
  • Impact of Technology on Adolescents
  • Patient-Provider Communication in Healthcare
  • Childhood Cancer Survivors' Quality of Life
  • Health Literacy and Information Accessibility
  • Interprofessional Education and Collaboration
  • Cancer Diagnosis and Treatment
  • Indoor Air Quality and Microbial Exposure
  • Cancer-related cognitive impairment studies
  • Alcohol Consumption and Health Effects
  • Social Media and Politics
  • Nutrition and Health in Aging
  • Global Cancer Incidence and Screening
  • Health Policy Implementation Science
  • Social Media in Health Education
  • Patient Satisfaction in Healthcare
  • Thyroid Cancer Diagnosis and Treatment

University of North Carolina at Chapel Hill
2018-2025

Rutgers, The State University of New Jersey
2023-2024

University of Chicago
2024

National Opinion Research Center
2024

Johnson University
2023-2024

UNC Lineberger Comprehensive Cancer Center
2021-2022

Memorial Sloan Kettering Cancer Center
2015-2017

University of Rochester Medical Center
2015

The purpose of this study was to evaluate the efficacy and tolerability addition 2 monoclonal antibodies, bevacizumab cetuximab, cycles high-dose cisplatin administered concurrently with intensity-modulated radiation therapy (IMRT) for head neck squamous cell carcinoma (HNSCC).Patients newly diagnosed stage III/IVB (M0) HNSCC received cetuximab (400 mg/m(2) loading dose, followed by 250 weekly), (15 mg/kg, days 1 22), (50 , 1, 2, 22, 23) IMRT (70 Gy). primary endpoint progression-free...

10.1002/hed.24041 article EN Head & Neck 2015-03-17

Purpose Tobacco prevention media campaigns are an important tool to address youth tobacco use. We developed a theory-based perceived message effectiveness (PME) Scale use when vetting messages for campaigns. Methods Participants were national sample of N=623 US adolescents (ages 13–17 years) recruited from probability-based panel. In online experiment, we randomised view ads. All participants viewed ad on smoking or vaping the Food and Drug Administration’s The Real Cost campaign control...

10.1136/tobaccocontrol-2021-056929 article EN cc-by-nc Tobacco Control 2021-12-20

Little research has examined the spillover effects of tobacco communication campaigns, such as how anti-smoking ads affect vaping.

10.1093/ntr/ntac206 article EN Nicotine & Tobacco Research 2022-08-25

Detecting depression in primary care patients is suboptimal, especially among historically excluded populations. To improve screening rates, a clinic integrated the Patient Health Questionnaire (PHQ) Electronic Record (EHR) and clinical workflow. Patients completed PHQ on tablet waiting room, responses were available real time for staff to review with patients. This study examined implementation science outcomes using Reach, Effectiveness, Adoption, Implementation, Maintenance framework 3.0....

10.1037/ser0000937 article EN Psychological Services 2025-04-10

Perceived message effectiveness (PME) is a common metric to understand receptivity tobacco prevention messages, yet most measures have been developed with adults. We examined adolescents' interpretation of language within candidate items for new youth-targeted PME measure using cognitive interviewing. sought the meaning adolescents assigned our improve item wording.

10.1093/ntr/ntac127 article EN Nicotine & Tobacco Research 2022-05-14

Abstract Introduction Existing approaches in cancer survivorship care delivery have proven to be insufficient engage primary care. This study aimed identify stakeholder‐informed priorities improve engagement breast Methods Experts U.S. were invited participate a 4‐round online Delphi panel and evaluate for defining fostering care's survivorship. Panelists asked then assess (ratings of 1–9) the importance feasibility priority items support review group results reevaluate each item, aiming...

10.1002/cam4.7219 article EN cc-by Cancer Medicine 2024-04-30

Background: Individuals with a history of cancer increasingly seek health information from online resources, including NCI-designated Cancer Center websites. Centers receive NCI designation because they provide excellent care and engage in cutting-edge research. However, the presented on these webpages their accessibility is unknown. An evaluation survivorship-focused needed to assess survivorship webpages. Methods: We conducted an 64 Centers. evaluated where were housed, if there was clinic...

10.6004/jnccn.2024.7017 article EN Journal of the National Comprehensive Cancer Network 2024-08-16

Patient reported outcome measures (PROMs) are increasingly used in oncology care, but pharmacists providing direct patient care have been overlooked. We engaged and adults receiving oral oncolytics (chemotherapy medication taken by mouth) to develop a SmartForm© the electronic health record (EHR) for PROM monitoring. Pharmacists verbally ask side effect questions during routine telehealth encounters enter responses real time. Our development process was guided Knowledge Action Framework. In...

10.1007/s11136-024-03789-8 article EN cc-by-nc-nd Quality of Life Research 2024-10-15

Many US health departments (HDs) conduct in-person quality improvement (QI) coaching to help primary care clinics improve their HPV vaccine delivery systems and communication. Some HDs additionally remote communication training prescribers recommend vaccination more effectively. Our aim was compare QI on key implementation outcomes. In a cluster randomized trial, we offered 855 clinics: 1) coaching; 2) training; or 3) both interventions combined. each trial arm, assessed adoption (proportion...

10.1093/tbm/ibab071 article EN Translational Behavioral Medicine 2021-07-09

6077 Background: Concurrent chemoradiation (CTRT) improves outcomes in oropharyngeal cancer (OPC) but causes toxicities that alter body composition. In other cancers, loss of lean mass (sarcopenia) is associated with poor prognosis. Changes composition OPC, and the clinical importance these alterations, have not been studied. Methods: Using a retrospective design, 234 OPC patients (mean age, 58 years (range 27 to 83); mean BMI, 29 kg/m2) receiving definitive CTRT were Skeletal muscle...

10.1200/jco.2016.34.15_suppl.6077 article EN Journal of Clinical Oncology 2016-05-20

Background: The Thyroid Cancer Care Collaborative developed a web-based clinical decision-making module (CDMM) to inform riskadjusted decisions on post-thyroidectomy radioactive iodine (RAI) use in papillary thyroid cancer (PTC). Methods: In pilot study, we evaluated the CDMM 19 PTC cases representing low- (five), intermediate- (seven) and high-risk disease. Two experts 10 physicians reviewed assigned risk level RAI recommendation. used standard approach while others CDMM. We assessed...

10.17925/ee.2017.13.01.26 article EN touchREVIEWS in Endocrinology 2017-01-01

Background: Despite calls for an enhanced role primary care individuals with a history of cancer, medical care's in adult survivorship continues to be marginal.Methods: We conducted in-depth interviews 8 oncologists interest cancer from 7 National Cancer Institute designated comprehensive centers understand perspectives on the survivorship.Results: Two salient overarching thematic patterns emerged. (1) Oncologist's diverge if, how, and when clinicians should involved survivorship, ranging...

10.1177/10732748231195436 article EN cc-by-nc Cancer Control 2023-01-01

Abstract Background Advances in detection and treatment for breast cancer have led to an increase the number of individuals managing significant late long-term effects. Primary care has a role caring patients with history cancer, yet there is little guidance on how effectively implement survivorship evidence into primary delivery. Methods This protocol describes multi-phase, mixed methods, stakeholder-driven research process that prioritizes actionable, evidence-based improvements enhance by...

10.1186/s12875-023-02186-3 article EN cc-by BMC Primary Care 2023-11-09

Despite 2 decades of cancer survivorship research, policy, and advocacy, primary care in the United States has not fully integrated into its generalist role. This manuscript describes innovative roles physicians have adopted how these emerged.

10.3122/jabfm.2023.230223r1 article EN The Journal of the American Board of Family Medicine 2024-05-01

The US's 64 CDC-funded immunization programs are at the forefront of efforts to improve quality adolescent vaccination services. We sought understand program managers' perspectives on partnering with healthcare systems HPV vaccine uptake. Managers 44 state and local completed our online survey in 2019. Immunization managers strongly endorsed importance uptake (mean = 3.8/4.0), most wanted do so next year 3.5). reported that common barriers included difficulty contacting systems' leadership...

10.1080/21645515.2021.1993041 article EN Human Vaccines & Immunotherapeutics 2021-10-29

<h3>Context:</h3> The IOM, NCI and professional organizations have endorsed an active role for primary care in the of individuals with a history cancer. While has not adopted this widely, innovations survivorship delivery emerged recent years. <h3>Objective:</h3> To describe emerging forms delivery. <h3>Study design analysis:</h3> As part larger NCI-funded study, we used snowball sampling to recruit 11 clinician innovators qualitative depth interviews before reaching saturation. We performed...

10.1370/afm.21.s1.3654 article EN 2023-01-01

e24040 Background: Although healthcare leaders in the US support an active role for primary care (PC) of patients with a history breast cancer, nature this remains unclear. Methods: We invited 40 innovators cancer survivorship to participate 4-round online Delphi panel identify strategies defining and fostering PC’s survivorship. Innovators included physicians, oncologists, researchers policy makers from government professional organizations participating programs US. Round 1 elicited...

10.1200/jco.2023.41.16_suppl.e24040 article EN Journal of Clinical Oncology 2023-06-01

e21652 Background: We assessed the feasibility of using PROs as part routine care to better understand trajectory in quality life (QOL) following treatment OPC. Methods: The Memorial Sloan Kettering Cancer Center (MSK) head and neck disease management team (DMT) assembled a parsimonious paper survey composed validated PRO measures (EORTC QLQ 30 HN-35, Neck Dissection Impairment Index, Skindex-16, COST-FACT) assess QOL at baseline, immediately 3 months post treatment. From Jan-May 2016, DMT...

10.1200/jco.2017.35.15_suppl.e21652 article EN Journal of Clinical Oncology 2017-05-20
Coming Soon ...